|
Contents
|
|
|
|
|
|
|
Astrocytic
Tumors
|
|
|
|
|
Groenendijk
FH, Taal W, Dubbink HJ, Haarloo CR, Kouwenhoven MC, van den Bent MJ, Kros JM,
Dinjens WN.
MGMT promoter hypermethylation is a frequent, early, and consistent event in
astrocytoma progression, and not correlated with TP53 mutation
J Neurooncol. 2010 Jul 1;. [Epub ahead of print]
.JPG)
Abstract |
.png)
Full Text |
.png)
Reprint
|
|
|
Khattab AZ, Ahmed MI, Fouad MA, Essa WA.
Significance of p53 and CD31 in astrogliomas
Med Oncol. 2008 Sep 20; [Epub ahead of print]
Abstract
|
|
|
Gliomas
|
|
|
|
|
Blough
MD, Beauchamp DC, Westgate MR, Kelly JJ, Cairncross JG
Effect
of aberrant p53 function on temozolomide sensitivity of glioma cell lines
and brain tumor initiating cells from glioblastoma
J
Neurooncol. 2010 Jul 1. [Epub ahead of print]
Abstract
|
|
|
Gliomas
(High-Grade)
|
|
|
|
|
Kang
HC, Kim CY, Han JH, Choe GY, Kim JH, Kim JH, Kim IA
Pseudoprogression
in patients with malignant gliomas treated with concurrent temozolomide and
radiotherapy: potential role of p53
J
Neurooncol. 2010 Jul 15. [Epub ahead of print]
Abstract
|
|
